| abstract |
The present invention relates to novel glucagons, the use of said glucagon peptides in therapy, methods of treatment comprising administering said glucagon peptides to patients in need thereof and the preparation of said glucagon peptides Uses in medicine. The glucagon peptides of the invention are of particular value in the treatment of hyperglycemia, diabetes and obesity, and various diseases or conditions associated with hyperglycemia, diabetes and obesity. |